US could soon approve MDMA therapy — opening an era of psychedelic medicine

Sara Reardon

Nature, 2023, vol. 616, issue 7957, 428-430

Abstract: Perceptions have shifted dramatically in the past few years on the therapeutic value of illicit drugs such as ecstasy. But questions still linger about what FDA approval might look like.

Keywords: Drug discovery; Psychiatric disorders (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-023-01296-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:616:y:2023:i:7957:d:10.1038_d41586-023-01296-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-01296-3

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().